Patrick Y.

Patrick Y. currently serves as the Director, Global Pharmacovigilance Scientist Lead at Amgen, where they oversee safety assessment activities for rare diseases and manage a team of Pharmacovigilance Scientists. They have extensive experience in pharmacovigilance, having held leadership roles at companies such as Astellas Pharma and Horizon, where they guided safety strategies and regulatory compliance. Previously, Patrick also worked as an Executive Director focusing on risk management and signal surveillance for another organization. They hold a Pharm.D. from the University of Illinois Chicago and a B.S. in Biochemistry from the University of Illinois Urbana-Champaign.